NeoGenomics, Inc.
US ˙ NasdaqCM ˙ US64049M2098

Introduction

This page provides a comprehensive analysis of the known insider trading history of Steven A Ross. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Steven A Ross has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:NEO / NeoGenomics, Inc. CIO 43,334
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Steven A Ross. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases NEO / NeoGenomics, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in NEO / NeoGenomics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

NEO / NeoGenomics, Inc. Insider Trades
Insider Sales NEO / NeoGenomics, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in NEO / NeoGenomics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2018-05-10 NEO ROSS STEVEN A 81,999 10.7800 81,999 10.7800 883,949 1 10.88 8,200 0.93
2017-06-05 NEO ROSS STEVEN A 45,833 7.7900 45,833 7.7900 357,039
2017-06-02 NEO ROSS STEVEN A 15,000 7.6300 15,000 7.6300 114,450
2017-06-02 NEO ROSS STEVEN A 10,000 7.7900 10,000 7.7900 77,900
2016-05-18 NEO ROSS STEVEN A 18,000 8.5000 18,000 8.5000 153,000
2016-05-09 NEO ROSS STEVEN A 15,000 8.2200 15,000 8.2200 123,300
2016-04-29 NEO ROSS STEVEN A 112,500 8.1100 112,500 8.1100 912,375

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

NEO / NeoGenomics, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Steven A Ross as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2018-05-10 2018-05-10 4 NEO NEOGENOMICS INC
Stock Option (Right to Buy)
X - Other -21,666 43,334 -33.33 7.52 -162,928 325,872
2018-05-10 2018-05-10 4 NEO NEOGENOMICS INC
Stock Option (Right to Buy)
X - Other -26,666 13,334 -66.66 7.15 -190,662 95,338
2018-05-10 2018-05-10 4 NEO NEOGENOMICS INC
Stock Option (Right to Buy)
X - Other -33,667 0 -100.00 4.78 -160,928
2018-05-10 2018-05-10 4 NEO NEOGENOMICS INC
Common Stock
S - Sale -81,999 4,500 -94.80 10.78 -883,949 48,510
2018-05-10 2018-05-10 4 NEO NEOGENOMICS INC
Common Stock
M - Exercise 21,666 86,499 33.42 7.52 162,928 650,472
2018-05-10 2018-05-10 4 NEO NEOGENOMICS INC
Common Stock
M - Exercise 26,666 64,833 69.87 7.15 190,662 463,556
2018-05-10 2018-05-10 4 NEO NEOGENOMICS INC
Common Stock
M - Exercise 33,667 38,167 748.16 4.78 160,928 182,438
2018-02-28 2018-02-26 4 NEO NEOGENOMICS INC
Stock Option(Right to Buy)
A - Award 72,500 72,500 8.03 582,175 582,175
2017-06-06 2017-06-05 4 NEO NEOGENOMICS INC
Common stock
S - Sale -45,833 4,500 -91.06 7.79 -357,039 35,055
2017-06-06 2017-06-02 4 NEO NEOGENOMICS INC
Stock Option (Right to Buy)
X - Other -33,333 33,667 -49.75 4.78 -159,332 160,928
2017-06-06 2017-06-02 4 NEO NEOGENOMICS INC
Stock Option (Right to buy)
X - Other -37,500 0 -100.00 3.93 -147,375
2017-06-06 2017-06-02 4 NEO NEOGENOMICS INC
Common Stock
S - Sale -10,000 50,333 -16.57 7.79 -77,900 392,094
2017-06-06 2017-06-02 4 NEO NEOGENOMICS INC
Common Stock
S - Sale -15,000 60,333 -19.91 7.63 -114,450 460,341
2017-06-06 2017-06-02 4 NEO NEOGENOMICS INC
Common Stock
M - Exercise 33,333 75,333 79.36 4.78 159,332 360,092
2017-06-06 2017-06-02 4 NEO NEOGENOMICS INC
Common Stock
M - Exercise 37,500 42,000 833.33 3.93 147,375 165,060
2017-05-02 2017-04-28 4 NEO NEOGENOMICS INC
Stock Option (Right to Buy)
A - Award 65,000 65,000 7.52 488,800 488,800
2016-05-20 2016-05-18 4 NEO NEOGENOMICS INC
Stock Option (Right to buy)
X - Other -18,000 67,000 -21.18 4.78 -86,040 320,260
2016-05-20 2016-05-18 4 NEO NEOGENOMICS INC
Common Stock
S - Sale -18,000 4,500 -80.00 8.50 -153,000 38,250
2016-05-20 2016-05-18 4 NEO NEOGENOMICS INC
Common Stock
M - Exercise 18,000 22,500 400.00 4.78 86,040 107,550
2016-05-10 2016-05-09 4 NEO NEOGENOMICS INC
Stock Option (Right to Buy)
X - Other -15,000 85,000 -15.00 4.78 -71,700 406,300
2016-05-10 2016-05-09 4 NEO NEOGENOMICS INC
Common Stock
S - Sale -15,000 4,500 -76.92 8.22 -123,300 36,990
2016-05-10 2016-05-09 4 NEO NEOGENOMICS INC
Common Stock
M - Exercise 15,000 19,500 333.33 4.78 71,700 93,210
2016-05-03 2016-04-29 4 NEO NEOGENOMICS INC
Stock Option (Right to buy)
X - Other -112,500 37,500 -75.00 3.93 -442,125 147,375
2016-05-03 2016-04-29 4 NEO NEOGENOMICS INC
Common Stock
S - Sale -112,500 4,500 -96.15 8.11 -912,375 36,495
2016-05-03 2016-04-29 4 NEO NEOGENOMICS INC
Common Stock
M - Exercise 112,500 117,000 2,500.00 3.93 442,125 459,810
2016-05-03 2016-04-20 4 NEO NEOGENOMICS INC
Stock Option (Right to Buy)
A - Award 40,000 40,000 7.15 286,000 286,000
2015-05-06 2015-05-04 4 NEO NEOGENOMICS INC
Stock Options (Right to Buy)
A - Award 100,000 100,000 4.78 478,000 478,000
2013-11-18 3 NEO NEOGENOMICS INC
Common Stock
4,500
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)